Home • Search • Translate
From Wikipedia, the free encyclopedia
(Redirected from Draft:Kahn Sagol Maccabi)

The Kahn-Sagol-Maccabi for Research and Innovation
מכון קאהן-סגול-מכבי למחקר ולחדשנות ( Hebrew)
Type Medical research
Established2016
Location
Israel
Website www.ksminnovation.com

The Kahn-Sagol-Maccabi (KSM) for Research and Innovation (in Hebrew: מכון קאהן-סגול-מכבי למחקר ולחדשנות) is the Research and Innovation Center of Maccabi Healthcare Services. [1]

History

Founded in 2016 by Maccabi Health Services with the key support of Morris Kahn and Sami Sagaol, KSM promotes excellence in medical research. [2]

Formerly headed by Prof. Varda Shalev and currently headed by Dr. Tal Patalon, an active clinician specializing in family and emergency medicine and a dedicated researcher, [3] KSM comprises four specialized research departments: Big Data, [4] Biobank (housing Israel's largest biological sample database for research), [5] Clinical Studies, [6] and Epidemiological Studies. [7]

In its global outreach, KSM collaborates with leading technology firms, start-up companies, [8] academic institutions [9] and scientists worldwide, [10] and has forged research agreements with numerous health ministries, [11] [12] including those of United Arab Emirates [13] and Bahrain. [14]

Activities and services

Medical studies

KSM Center strives to enhance healthcare systems through independent research and partnerships with international researchers, [15] academic institutions, pharmaceutical companies, start-ups and technology firms. [16] [17]

Since its inception, the center has conducted hundreds of studies, [18] resulting in the development of tools for both patients and healthcare providers. [19] These studies have influenced medical policies in several countries, particularly during the COVID-19 pandemic. [20]

Notable studies conducted under KSM's auspices include:

  • Studies on the coronavirus epidemic - During the COVID-19 pandemic, several international scientific studies based on the Maccabi databases were conducted by the center, Including studies on repeated infection in children, [21] repeated infection in adults, [22] natural vaccination, [23] [20] [24] reduction of transmission [25] the decline in the effect of the third vaccine [26] the effect of the vaccine on intra-domestic infection [9] and on patients with Coeliac disease. [27]
  • Research on monkeypox - In 2023, a study on monkeypox based on KSM's analysis and database was published. [28]
  • Research on Parvovirus B19 - In 2023, a study on a local outbreak of parvovirus was published. [29]
  • Research on autism - In 2023, a study on late diagnosis of autism was published. [30]
  • Research on cancer – In 2023, a study of the effects of palbociclib treatment on the lifespan of patients with breast cancer was published. [31]

Medical database

KSM's research activities are based on independent efforts, as well as the extensive medical knowledge and database of Maccabi Health Services. [32] This database, compiled over three decades and anonymized, encompasses digital records of 2.7 million insured individuals. [33]

In addition to its in-house research, [34] the Center offers global researchers access to conduct studies, analyses [30] and medical prediction, [35] based on this comprehensive database. [36]

KSM's innovation and big data department leverages databases and artificial intelligence technologies, [37] [38] facilitating a wide range of research opportunities, analysis and medical prediction. [39]

Biobank

The KSM Center has established the Tipa BioBank, [5] Israel's largest biobank [40] housing over a million genetic samples for research purposes. [11] [19]

The purpose of this initiative is to develop tools for early disease detection through genetic [41] and biological studies. [8] A central feature of this effort is the creation of a repository of biological samples (e.g., blood, urine, etc.), enabling researchers to investigate how genetic profiles influence disease risk and treatment. [42]

Main publications

References

  1. ^ The Kahn-Sagol-Maccabi (KSM) Institute for Research and Innovation
  2. ^ "Kahn Sagol Maccabi". Guidestar. Retrieved 9 November 2023.
  3. ^ Rubinstein, Carrie (8 March 2023). "AI Is Taking Over Our Feelings: An Economist's Positive-Negative Prediction Of The Near Future". Forbes. Retrieved 26 October 2023.
  4. ^ Big data unit Kahn-Sagol-Maccabi (KSM)
  5. ^ a b The Tipa Biobank, Kahn-Sagol-Maccabi (KSM)
  6. ^ Clinical trial unit Kahn-Sagol-Maccabi (KSM)
  7. ^ Epidemiological studies, Kahn-Sagol-Maccabi (KSM)
  8. ^ a b Rubinstein, Carrie (12 July 2023). "Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare". Forbes. Retrieved 26 October 2023.
  9. ^ a b Prunas, Ottavia; Warren, Joshua L.; Crawford, Forrest W.; Gazit, Sivan; Patalon, Tal; Weinberger, Daniel M.; Pitzer, Virginia E. (2022). "Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel". Science. 375 (6585): 1151–1154. Bibcode: 2022Sci...375.1151P. doi: 10.1126/science.abl4292. PMC  9261115. PMID  35084937.
  10. ^ Kahn-Sagol-Maccabi (KSM), Maccabi Healthcare Services
  11. ^ a b "Abu Dhabi DoH and Kahn Sagol Maccabi (KSM) Sign an MoU to Cooperate in Technological Innovation and Healthcare Research". AP news. 1 February 2023. Retrieved 26 October 2023.
  12. ^ "Abu Dhabi health dept., Israeli health org pledge to cooperate on research". Jerusalem Post. 2 February 2023. Retrieved 26 October 2023.
  13. ^ "New UAE-Israel agreement to promote cancer, diabetes research". Khaleej Times. 13 July 2022. Retrieved 26 October 2023.
  14. ^ "Healing relationship - Bahrain and Maccabi in a strategic and groundbreaking research and innovation agreement". Ynet. 10 May 2022. Retrieved 26 October 2023.
  15. ^ Neesha Salian, SEHA and Israel’s leading HMO announce collaboration in research and digital health development, Gulf Business, 13 July 2022
  16. ^ Maccabi’s KSM Research and Innovation Center Announces Partnership with Rhino Health to Facilitate Healthcare Data Collaborations, Accesswire 25 October 2022
  17. ^ PrognomiQ, Maccabi Health Collaborating on Cancer Biomarker Development, 360dx.com, Jun 21, 2022
  18. ^ Professional publications, KSM Research and Innovation Center
  19. ^ a b Rubinstein, Carrie (9 September 2022). "Small-Big Data: A Healthcare Revolution In The Making". Forbes. Retrieved 26 October 2023.
  20. ^ a b Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  21. ^ Gazit, Sivan; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Stuart, Elizabeth A.; Patalon, Tal (2023). "Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: A target trial emulation". The Lancet Microbe. 4 (7): e495–e505. doi: 10.1016/S2666-5247(23)00103-9. PMC  10101759. PMID  37062294.
  22. ^ Gazit, S.; Shlezinger, R.; Perez, G.; Lotan, R.; Peretz, A.; Ben-Tov, A.; Herzel, E.; Alapi, H.; Cohen, D.; Muhsen, K.; Chodick, G.; Patalon, T. (2022). "The Incidence of SARS-CoV-2 Reinfection in Persons with Naturally Acquired Immunity with and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine: A Retrospective Cohort Study". Annals of Internal Medicine. 175 (5): 674–681. doi: 10.7326/M21-4130. PMC  8855786. PMID  35157493.
  23. ^ Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  24. ^ Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  25. ^ Van Boven, Michiel; Van Dorp, Christiaan H.; Westerhof, Ilse; Jaddoe, Vincent; Heuvelman, Valerie; Duijts, Liesbeth; Fourie, Elandri; Sluiter-Post, Judith; Van Houten, Marlies A.; Badoux, Paul; Euser, Sjoerd; Herpers, Bjorn; Eggink, Dirk; De Hoog, Marieke; Boom, Trisja; Wildenbeest, Joanne; Bont, Louis; Rozhnova, Ganna; Bonten, Marc J.; Kretzschmar, Mirjam E.; Bruijning-Verhagen, Patricia (2023). "Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study". medRxiv. doi: 10.1101/2023.06.02.23290879. PMC  10275010. PMID  37333399.
  26. ^ Patalon, Tal; Saciuk, Yaki; Peretz, Asaf; Perez, Galit; Lurie, Yoav; Maor, Yasmin; Gazit, Sivan (2022). "Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine". Nature Communications. 13 (1): 3203. Bibcode: 2022NatCo..13.3203P. doi: 10.1038/s41467-022-30884-6. PMC  9184525. PMID  35680872.
  27. ^ Ben-Tov, Amir; Lebwohl, Benjamin; Banon, Tamar; Chodick, Gabriel; Kariv, Revital; Assa, Amit; Gazit, Sivan; Patalon, Tal (2023). "BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign". Viruses. 15 (9): 1968. doi: 10.3390/v15091968. PMID  37766374.
  28. ^ Patalon, Tal; Perez, Galit; Saciuk, Yaki; Refaeli, Ziva; Gazit, Sivan (2023). "Mpox Patient Journey in Israel". Microorganisms. 11 (4): 1042. doi: 10.3390/microorganisms11041042. PMC  10145053. PMID  37110465.
  29. ^ Patalon, Tal; Saciuk, Yaki; Trotzky, Daniel; Pachys, Gal; Ben-Tov, Amir; Segal, Yaakov; Gazit, Sivan (2023). "An Outbreak of Parvovirus B19 in Israel". Viruses. 15 (11): 2261. doi: 10.3390/v15112261. PMC  10674631. PMID  38005937.
  30. ^ Davidovitch, Michael; Gazit, Sivan; Patalon, Tal; Leitner, Yael; Rotem, Ran S. (2023). "Late diagnosis of autism spectrum disorder—Journey, parents' concerns, and sex influences". Autism Research. 16 (2): 294–301. doi: 10.1002/aur.2869. PMID  36495248. S2CID  254561408.
  31. ^ Moser, Sarah Sharman; Mazursky, Orr Friedman; Shalev, Hadas; Apter, Lior; Chodick, Gabriel; Siegelmann-Danieli, Nava (2023). "Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations". Future Oncology. 19 (21): 1473–1483. doi: 10.2217/fon-2023-0176. PMID  37529919.
  32. ^ Valo Health, KSM research and innovation center and Valo health announce first of its kind multiyear collaboration to spearhead preventive care and personalized medicine for patients, 19 Sep, 2022
  33. ^ Kraus, Yair (1 August 2023). ""Artificial intelligence is going to lead to a change the likes of which we haven't seen in years in the world of medicine"". Ynet. Retrieved 9 November 2023.
  34. ^ Yanko, Adir (25 March 2021). "A significant increase in the diagnosis of young celiac patients in Israel - what are the reasons for this?". Ynet. Retrieved 26 October 2023.
  35. ^ Yechezkel, Matan; Mofaz, Merav; Painsky, Amichai; Patalon, Tal; Gazit, Sivan; Shmueli, Erez; Yamin, Dan (2023). "Safety of the fourth COVID-19 BNT162b2 mRNA (Second booster) vaccine: A prospective and retrospective cohort study". The Lancet Respiratory Medicine. 11 (2): 139–150. doi: 10.1016/S2213-2600(22)00407-6. PMC  9889528. PMID  36410364.
  36. ^ Weinerb, Gali (1 December 2020). "Predicting illnesses and hospitalizations: the vision of the director of the Maccabi Research Institute". Globes. Retrieved 26 October 2023.
  37. ^ Danny Sullivan, ongevity AI partners with Israel’s leading HMO, Technology, April 4, 2023
  38. ^ IBEX Introduces Galen Gastric, World’s First AI-Powered Solution For Gastrointestinal Cancer Diagnostics, At Maccabi Healthcare Services, AIthority.com, Aug 24, 2021
  39. ^ Suresh, Somasetty (25 October 2023). "New Study Shows Pfizer COVID-19 Vaccine Equally Effective for Patients with Celiac Disease". Express Healthcare Management. Retrieved 26 October 2023.
  40. ^ KSM Research And Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment, August 15, 2022
  41. ^ G42 Healthcare, KSM enter first UAE-Israel genetic research collaboration - Arabian Business, Arabian Business, 2 March 2022
  42. ^ Israel and UAE to collaborate on cancer and diabetes research, MiddleEastMonitor ,14 July 2022

External links

Retrieved from " https://en.wikipedia.org/?title=Kahn_Sagol_Maccabi&oldid=1221164214"
From Wikipedia, the free encyclopedia
(Redirected from Draft:Kahn Sagol Maccabi)

The Kahn-Sagol-Maccabi for Research and Innovation
מכון קאהן-סגול-מכבי למחקר ולחדשנות ( Hebrew)
Type Medical research
Established2016
Location
Israel
Website www.ksminnovation.com

The Kahn-Sagol-Maccabi (KSM) for Research and Innovation (in Hebrew: מכון קאהן-סגול-מכבי למחקר ולחדשנות) is the Research and Innovation Center of Maccabi Healthcare Services. [1]

History

Founded in 2016 by Maccabi Health Services with the key support of Morris Kahn and Sami Sagaol, KSM promotes excellence in medical research. [2]

Formerly headed by Prof. Varda Shalev and currently headed by Dr. Tal Patalon, an active clinician specializing in family and emergency medicine and a dedicated researcher, [3] KSM comprises four specialized research departments: Big Data, [4] Biobank (housing Israel's largest biological sample database for research), [5] Clinical Studies, [6] and Epidemiological Studies. [7]

In its global outreach, KSM collaborates with leading technology firms, start-up companies, [8] academic institutions [9] and scientists worldwide, [10] and has forged research agreements with numerous health ministries, [11] [12] including those of United Arab Emirates [13] and Bahrain. [14]

Activities and services

Medical studies

KSM Center strives to enhance healthcare systems through independent research and partnerships with international researchers, [15] academic institutions, pharmaceutical companies, start-ups and technology firms. [16] [17]

Since its inception, the center has conducted hundreds of studies, [18] resulting in the development of tools for both patients and healthcare providers. [19] These studies have influenced medical policies in several countries, particularly during the COVID-19 pandemic. [20]

Notable studies conducted under KSM's auspices include:

  • Studies on the coronavirus epidemic - During the COVID-19 pandemic, several international scientific studies based on the Maccabi databases were conducted by the center, Including studies on repeated infection in children, [21] repeated infection in adults, [22] natural vaccination, [23] [20] [24] reduction of transmission [25] the decline in the effect of the third vaccine [26] the effect of the vaccine on intra-domestic infection [9] and on patients with Coeliac disease. [27]
  • Research on monkeypox - In 2023, a study on monkeypox based on KSM's analysis and database was published. [28]
  • Research on Parvovirus B19 - In 2023, a study on a local outbreak of parvovirus was published. [29]
  • Research on autism - In 2023, a study on late diagnosis of autism was published. [30]
  • Research on cancer – In 2023, a study of the effects of palbociclib treatment on the lifespan of patients with breast cancer was published. [31]

Medical database

KSM's research activities are based on independent efforts, as well as the extensive medical knowledge and database of Maccabi Health Services. [32] This database, compiled over three decades and anonymized, encompasses digital records of 2.7 million insured individuals. [33]

In addition to its in-house research, [34] the Center offers global researchers access to conduct studies, analyses [30] and medical prediction, [35] based on this comprehensive database. [36]

KSM's innovation and big data department leverages databases and artificial intelligence technologies, [37] [38] facilitating a wide range of research opportunities, analysis and medical prediction. [39]

Biobank

The KSM Center has established the Tipa BioBank, [5] Israel's largest biobank [40] housing over a million genetic samples for research purposes. [11] [19]

The purpose of this initiative is to develop tools for early disease detection through genetic [41] and biological studies. [8] A central feature of this effort is the creation of a repository of biological samples (e.g., blood, urine, etc.), enabling researchers to investigate how genetic profiles influence disease risk and treatment. [42]

Main publications

References

  1. ^ The Kahn-Sagol-Maccabi (KSM) Institute for Research and Innovation
  2. ^ "Kahn Sagol Maccabi". Guidestar. Retrieved 9 November 2023.
  3. ^ Rubinstein, Carrie (8 March 2023). "AI Is Taking Over Our Feelings: An Economist's Positive-Negative Prediction Of The Near Future". Forbes. Retrieved 26 October 2023.
  4. ^ Big data unit Kahn-Sagol-Maccabi (KSM)
  5. ^ a b The Tipa Biobank, Kahn-Sagol-Maccabi (KSM)
  6. ^ Clinical trial unit Kahn-Sagol-Maccabi (KSM)
  7. ^ Epidemiological studies, Kahn-Sagol-Maccabi (KSM)
  8. ^ a b Rubinstein, Carrie (12 July 2023). "Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare". Forbes. Retrieved 26 October 2023.
  9. ^ a b Prunas, Ottavia; Warren, Joshua L.; Crawford, Forrest W.; Gazit, Sivan; Patalon, Tal; Weinberger, Daniel M.; Pitzer, Virginia E. (2022). "Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel". Science. 375 (6585): 1151–1154. Bibcode: 2022Sci...375.1151P. doi: 10.1126/science.abl4292. PMC  9261115. PMID  35084937.
  10. ^ Kahn-Sagol-Maccabi (KSM), Maccabi Healthcare Services
  11. ^ a b "Abu Dhabi DoH and Kahn Sagol Maccabi (KSM) Sign an MoU to Cooperate in Technological Innovation and Healthcare Research". AP news. 1 February 2023. Retrieved 26 October 2023.
  12. ^ "Abu Dhabi health dept., Israeli health org pledge to cooperate on research". Jerusalem Post. 2 February 2023. Retrieved 26 October 2023.
  13. ^ "New UAE-Israel agreement to promote cancer, diabetes research". Khaleej Times. 13 July 2022. Retrieved 26 October 2023.
  14. ^ "Healing relationship - Bahrain and Maccabi in a strategic and groundbreaking research and innovation agreement". Ynet. 10 May 2022. Retrieved 26 October 2023.
  15. ^ Neesha Salian, SEHA and Israel’s leading HMO announce collaboration in research and digital health development, Gulf Business, 13 July 2022
  16. ^ Maccabi’s KSM Research and Innovation Center Announces Partnership with Rhino Health to Facilitate Healthcare Data Collaborations, Accesswire 25 October 2022
  17. ^ PrognomiQ, Maccabi Health Collaborating on Cancer Biomarker Development, 360dx.com, Jun 21, 2022
  18. ^ Professional publications, KSM Research and Innovation Center
  19. ^ a b Rubinstein, Carrie (9 September 2022). "Small-Big Data: A Healthcare Revolution In The Making". Forbes. Retrieved 26 October 2023.
  20. ^ a b Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  21. ^ Gazit, Sivan; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Stuart, Elizabeth A.; Patalon, Tal (2023). "Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: A target trial emulation". The Lancet Microbe. 4 (7): e495–e505. doi: 10.1016/S2666-5247(23)00103-9. PMC  10101759. PMID  37062294.
  22. ^ Gazit, S.; Shlezinger, R.; Perez, G.; Lotan, R.; Peretz, A.; Ben-Tov, A.; Herzel, E.; Alapi, H.; Cohen, D.; Muhsen, K.; Chodick, G.; Patalon, T. (2022). "The Incidence of SARS-CoV-2 Reinfection in Persons with Naturally Acquired Immunity with and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine: A Retrospective Cohort Study". Annals of Internal Medicine. 175 (5): 674–681. doi: 10.7326/M21-4130. PMC  8855786. PMID  35157493.
  23. ^ Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  24. ^ Patalon, Tal; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Ben-Tov, Amir; Gazit, Sivan (2023). "Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents". The Journal of Pediatrics. 257. doi: 10.1016/j.jpeds.2023.02.016. PMC  9981270. PMID  36870558.
  25. ^ Van Boven, Michiel; Van Dorp, Christiaan H.; Westerhof, Ilse; Jaddoe, Vincent; Heuvelman, Valerie; Duijts, Liesbeth; Fourie, Elandri; Sluiter-Post, Judith; Van Houten, Marlies A.; Badoux, Paul; Euser, Sjoerd; Herpers, Bjorn; Eggink, Dirk; De Hoog, Marieke; Boom, Trisja; Wildenbeest, Joanne; Bont, Louis; Rozhnova, Ganna; Bonten, Marc J.; Kretzschmar, Mirjam E.; Bruijning-Verhagen, Patricia (2023). "Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study". medRxiv. doi: 10.1101/2023.06.02.23290879. PMC  10275010. PMID  37333399.
  26. ^ Patalon, Tal; Saciuk, Yaki; Peretz, Asaf; Perez, Galit; Lurie, Yoav; Maor, Yasmin; Gazit, Sivan (2022). "Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine". Nature Communications. 13 (1): 3203. Bibcode: 2022NatCo..13.3203P. doi: 10.1038/s41467-022-30884-6. PMC  9184525. PMID  35680872.
  27. ^ Ben-Tov, Amir; Lebwohl, Benjamin; Banon, Tamar; Chodick, Gabriel; Kariv, Revital; Assa, Amit; Gazit, Sivan; Patalon, Tal (2023). "BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign". Viruses. 15 (9): 1968. doi: 10.3390/v15091968. PMID  37766374.
  28. ^ Patalon, Tal; Perez, Galit; Saciuk, Yaki; Refaeli, Ziva; Gazit, Sivan (2023). "Mpox Patient Journey in Israel". Microorganisms. 11 (4): 1042. doi: 10.3390/microorganisms11041042. PMC  10145053. PMID  37110465.
  29. ^ Patalon, Tal; Saciuk, Yaki; Trotzky, Daniel; Pachys, Gal; Ben-Tov, Amir; Segal, Yaakov; Gazit, Sivan (2023). "An Outbreak of Parvovirus B19 in Israel". Viruses. 15 (11): 2261. doi: 10.3390/v15112261. PMC  10674631. PMID  38005937.
  30. ^ Davidovitch, Michael; Gazit, Sivan; Patalon, Tal; Leitner, Yael; Rotem, Ran S. (2023). "Late diagnosis of autism spectrum disorder—Journey, parents' concerns, and sex influences". Autism Research. 16 (2): 294–301. doi: 10.1002/aur.2869. PMID  36495248. S2CID  254561408.
  31. ^ Moser, Sarah Sharman; Mazursky, Orr Friedman; Shalev, Hadas; Apter, Lior; Chodick, Gabriel; Siegelmann-Danieli, Nava (2023). "Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations". Future Oncology. 19 (21): 1473–1483. doi: 10.2217/fon-2023-0176. PMID  37529919.
  32. ^ Valo Health, KSM research and innovation center and Valo health announce first of its kind multiyear collaboration to spearhead preventive care and personalized medicine for patients, 19 Sep, 2022
  33. ^ Kraus, Yair (1 August 2023). ""Artificial intelligence is going to lead to a change the likes of which we haven't seen in years in the world of medicine"". Ynet. Retrieved 9 November 2023.
  34. ^ Yanko, Adir (25 March 2021). "A significant increase in the diagnosis of young celiac patients in Israel - what are the reasons for this?". Ynet. Retrieved 26 October 2023.
  35. ^ Yechezkel, Matan; Mofaz, Merav; Painsky, Amichai; Patalon, Tal; Gazit, Sivan; Shmueli, Erez; Yamin, Dan (2023). "Safety of the fourth COVID-19 BNT162b2 mRNA (Second booster) vaccine: A prospective and retrospective cohort study". The Lancet Respiratory Medicine. 11 (2): 139–150. doi: 10.1016/S2213-2600(22)00407-6. PMC  9889528. PMID  36410364.
  36. ^ Weinerb, Gali (1 December 2020). "Predicting illnesses and hospitalizations: the vision of the director of the Maccabi Research Institute". Globes. Retrieved 26 October 2023.
  37. ^ Danny Sullivan, ongevity AI partners with Israel’s leading HMO, Technology, April 4, 2023
  38. ^ IBEX Introduces Galen Gastric, World’s First AI-Powered Solution For Gastrointestinal Cancer Diagnostics, At Maccabi Healthcare Services, AIthority.com, Aug 24, 2021
  39. ^ Suresh, Somasetty (25 October 2023). "New Study Shows Pfizer COVID-19 Vaccine Equally Effective for Patients with Celiac Disease". Express Healthcare Management. Retrieved 26 October 2023.
  40. ^ KSM Research And Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment, August 15, 2022
  41. ^ G42 Healthcare, KSM enter first UAE-Israel genetic research collaboration - Arabian Business, Arabian Business, 2 March 2022
  42. ^ Israel and UAE to collaborate on cancer and diabetes research, MiddleEastMonitor ,14 July 2022

External links

Retrieved from " https://en.wikipedia.org/?title=Kahn_Sagol_Maccabi&oldid=1221164214"

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook




Top Of Page

Home • Search • Translate

© CSE